Yongzhong Du

15.2k total citations · 4 hit papers
265 papers, 12.0k citations indexed

About

Yongzhong Du is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Yongzhong Du has authored 265 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Biomedical Engineering, 94 papers in Biomaterials and 92 papers in Molecular Biology. Recurrent topics in Yongzhong Du's work include Nanoplatforms for cancer theranostics (90 papers), Nanoparticle-Based Drug Delivery (85 papers) and RNA Interference and Gene Delivery (42 papers). Yongzhong Du is often cited by papers focused on Nanoplatforms for cancer theranostics (90 papers), Nanoparticle-Based Drug Delivery (85 papers) and RNA Interference and Gene Delivery (42 papers). Yongzhong Du collaborates with scholars based in China, Japan and Czechia. Yongzhong Du's co-authors include Fuqiang Hu, Hong Yuan, Jian You, Xiaoying Ying, Su Zeng, Xiaoling Xu, Saiping Jiang, Lihua Luo, Chunqi Zhu and Jing Qi and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Yongzhong Du

253 papers receiving 11.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death

2019 939 citations Lihua Luo, Mengshi Jiang et al. profile →
ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury

2020 266 citations Hui Yu, Feiyang Jin et al. Theranostics profile →
Adipose‐Derived Mesenchymal Stem Cell‐Derived Exosomes Biopotentiated Extracellular Matrix Hydrogels Accelerate Diabetic Wound Healing and Skin Regeneration

2023 153 citations Yanling Song, Yuchan You et al. Advanced Science profile →
Programmed enhancement of endogenous iron-mediated lysosomal membrane permeabilization for tumor ferroptosis/pyroptosis dual-induction

2025 16 citations Luwen Zhu, Jiahao Hu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yongzhong Du China	59	4.5k	4.1k	4.1k	2.3k	1.7k	265	12.0k
Jayanth Panyam United States	43	3.3k 0.7×	5.0k 1.2×	4.4k 1.1×	2.5k 1.1×	1.3k 0.8×	97	11.3k
Yu Zhang China	57	3.2k 0.7×	3.4k 0.8×	3.6k 0.9×	2.0k 0.9×	1.4k 0.8×	508	12.5k
Jianqing Gao China	69	4.3k 0.9×	3.8k 0.9×	6.2k 1.5×	1.8k 0.8×	1.7k 1.0×	343	14.6k
Zhonggui He China	58	6.2k 1.4×	5.1k 1.3×	5.1k 1.3×	1.7k 0.7×	2.0k 1.2×	403	13.6k
Fatemeh Atyabi Iran	63	3.6k 0.8×	5.5k 1.3×	4.5k 1.1×	3.0k 1.3×	1.3k 0.8×	331	13.2k
Aaron C. Anselmo United States	41	4.4k 1.0×	4.0k 1.0×	4.1k 1.0×	1.4k 0.6×	1.9k 1.1×	69	11.5k
Jinqiang Wang China	51	5.4k 1.2×	3.2k 0.8×	3.6k 0.9×	2.2k 0.9×	1.2k 0.7×	117	11.2k
Fabienne Danhier Belgium	33	4.7k 1.0×	5.9k 1.4×	3.6k 0.9×	1.5k 0.6×	1.1k 0.6×	41	10.3k
Sanjeeb Kumar Sahoo India	49	5.1k 1.1×	7.3k 1.8×	5.0k 1.2×	2.7k 1.2×	2.4k 1.4×	117	15.2k
Han‐Gon Choi South Korea	65	3.7k 0.8×	4.3k 1.1×	3.8k 0.9×	6.0k 2.6×	2.2k 1.3×	332	14.4k

Countries citing papers authored by Yongzhong Du

Since Specialization

Citations

This map shows the geographic impact of Yongzhong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongzhong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongzhong Du more than expected).

Fields of papers citing papers by Yongzhong Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongzhong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongzhong Du. The network helps show where Yongzhong Du may publish in the future.

Co-authorship network of co-authors of Yongzhong Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yongzhong Du. A scholar is included among the top collaborators of Yongzhong Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongzhong Du. Yongzhong Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Luwen & Yongzhong Du. (2024). A promising new approach to cancer therapy: Manipulate ferroptosis by hijacking endogenous iron. International Journal of Pharmaceutics. 662. 124517–124517. 5 indexed citations

Lu, Yuan‐Fei, Xiaoyan Yang, Xiaojie Wang, et al.. (2024). Acid-etched layered double hydroxides armed with dual “Doorkeepers” for Immunomodulatory-NIR III photodynamic therapy of hepatocellular carcinoma. Chemical Engineering Journal. 481. 148610–148610. 6 indexed citations

Lu, Yao, et al.. (2024). Trap & kill: a neutrophil-extracellular-trap mimic nanoparticle for anti-bacterial therapy. Biomaterials Science. 12(7). 1841–1846. 3 indexed citations

Chen, Xiaoxiao, Muhammad Sohail, Fazong Wu, et al.. (2024). Self-targeted smart polyester nanoparticles for simultaneous Delivery of photothermal and chemotherapeutic agents for efficient treatment of HCC. Biomaterials Science. 12(24). 6368–6381.

Sun, Mingchen, Ying-Fang Chen, Di Liu, et al.. (2023). Effective decolonization strategy for mupirocin-resistant Staphylococcus aureus by TPGS-modified mupirocin-silver complex. Materials Today Bio. 18. 100534–100534. 5 indexed citations

Song, Yanling, Yuchan You, Xinyi Xu, et al.. (2023). Adipose‐Derived Mesenchymal Stem Cell‐Derived Exosomes Biopotentiated Extracellular Matrix Hydrogels Accelerate Diabetic Wound Healing and Skin Regeneration. Advanced Science. 10(30). e2304023–e2304023. 153 indexed citations breakdown →

You, Yuchan, Feiyang Jin, Luwen Zhu, et al.. (2023). A photo-activable nano-agonist for the two-signal model of T cell in vivo activation. Journal of Controlled Release. 361. 681–693. 3 indexed citations

Lou, Xue-Fang, Jingyi Lu, Chen Wang, et al.. (2023). Self-oriented ferritin nanocages mitigate iron overload-induced oxidative stress for acute kidney injury. Chemical Engineering Journal. 466. 143227–143227. 14 indexed citations

Lu, Nannan, Xiaojuan Wang, Yongzhong Du, et al.. (2023). Targeted delivery of β-carotene potentially prevents blood-brain barrier breakdown after stroke in mice. Phytomedicine Plus. 3(2). 100426–100426. 3 indexed citations

10.

Du, Yongzhong, et al.. (2023). Nanodrug Delivery Strategies to Signaling Pathways in Alopecia. Molecular Pharmaceutics. 20(11). 5396–5415. 5 indexed citations

11.

Xu, Xiaoling, et al.. (2023). Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments. Journal of Nanobiotechnology. 21(1). 105–105. 25 indexed citations

12.

Luo, Zhenyu, Lihua Luo, Yichao Lu, et al.. (2022). Dual-binding nanoparticles improve the killing effect of T cells on solid tumor. Journal of Nanobiotechnology. 20(1). 261–261. 12 indexed citations

13.

Jin, Feiyang, Jing Qi, Minxia Zhu, et al.. (2020). NIR-Triggered Sequentially Responsive Nanocarriers Amplified Cascade Synergistic Effect of Chemo-Photodynamic Therapy with Inspired Antitumor Immunity. ACS Applied Materials & Interfaces. 12(29). 32372–32387. 43 indexed citations

14.

Shu, Gaofeng, Chenying Lu, Zhixian Wang, et al.. (2020). Fucoidan-based micelles as P-selectin targeted carriers for synergistic treatment of acute kidney injury. Nanomedicine Nanotechnology Biology and Medicine. 32. 102342–102342. 27 indexed citations

15.

Qi, Jing, Xiaoling Xu, Feiyang Jin, et al.. (2020). Cyto-friendly polymerization at cell surfaces modulates cell fate by clustering cell-surface receptors. Chemical Science. 11(16). 4221–4225. 26 indexed citations

16.

Liu, Di, Gaofeng Shu, Feiyang Jin, et al.. (2020). ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule. Science Advances. 6(41). 161 indexed citations

17.

Yu, Hui, Feiyang Jin, Di Liu, et al.. (2020). ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Theranostics. 10(5). 2342–2357. 266 indexed citations breakdown →

18.

Liu, Ping, Wei-Shuo Li, Jian You, et al.. (2015). High tolerated paclitaxel nano-formulation delivered by poly (lactic-co-glycolic acid)-g-dextran micelles to efficient cancer therapy. Nanomedicine Nanotechnology Biology and Medicine. 11(4). 855–866. 52 indexed citations

19.

Hou, Yiping, et al.. (2009). Sequence analysis and over-expression of ribosomal protein S28 gene (RPS28) from the Giant Panda. AFRICAN JOURNAL OF BIOTECHNOLOGY. 8(11). 2454–2459. 1 indexed citations

20.

Taira, Shu, Yongzhong Du, Y. Hiratsuka, et al.. (2007). Loading and unloading of molecular cargo by DNA‐conjugated microtubule. Biotechnology and Bioengineering. 99(3). 734–739. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact